Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report published on Friday morning. The brokerage issued a buy rating on the health services provider’s stock. Several other brokerages have also recently weighed in on AMED. TD Cowen increased their price target on shares of Amedisys from $84.00 to $101.00 and […]
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Friday. The firm issued a buy rating on the health services provider’s stock. Other equities analysts have also issued reports about the company. Truist Financial raised their target price on Amedisys from $97.00 to $101.00 in a report […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Thursday. The brokerage issued a buy rating on the health services provider’s stock. Other research analysts also recently issued research reports about the stock. Credit Suisse Group downgraded shares of Amedisys from an outperform rating to a neutral […]
Amedisys (NASDAQ:AMED – Get Free Report) posted its quarterly earnings data on Wednesday. The health services provider reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.28, Briefing.com reports. Amedisys had a net margin of 5.02% and a return on equity of 14.35%. The firm had revenue of […]
Amedisys (NASDAQ:AMED – Get Free Report) will post its quarterly earnings results on Tuesday, July 25th. Amedisys (NASDAQ:AMED – Get Free Report) last issued its quarterly earnings results on Thursday, May 4th. The health services provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.14. Amedisys had a […]